Corporate Banner
Satellite Banner
Informatics
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

PerkinElmer Releases Newest Version of Flagship Informatics Product: ChemBioOffice® Ultra 13.0 Suite

Published: Thursday, August 30, 2012
Last Updated: Thursday, August 30, 2012
Bookmark and Share
New informatics product accelerates the discovery process through increased productivity and data sharing

PerkinElmer, Inc., a global leader focused on improving the health and safety of people and the environment, has introduced the newest version of ChemBioOffice® Informatics Suite. Version 13.0 increases the productivity of scientists with improvements to the industry leading ChemBioDraw® and ChemBio3D® modules while providing secure cloud storage for improved data sharing.

The ChemBioOffice suite helps chemists and biologists to efficiently track their work giving scientists more time to focus on their research, visualize and gain a deeper understanding of their results and correlate biological activity and other properties with chemical structures. The new informatics product provides individual scientists within an organization the tools they need to create publication-ready drawings of compounds, reactions, materials and their properties for use in electronic laboratory notebooks (ELNs) and databases as well as for querying chemical databases.

“A pressing challenge for our customers is to continually introduce new product candidates into the research and development pipeline in order to maintain competitiveness and ensure ongoing revenues,” said Michael Stapleton, general manager of PerkinElmer Informatics. “We are very excited to provide chemists and biologists with the new ChemBioOffice Suite, a premium tool developed to help scientists turn data into actionable information and make decisions with greater confidence, thereby accelerating their discovery process.”

The improved biopolymer toolbar of the ChemBioDraw program, the world’s leading scientific drawing program, enables fast and easy modifications to larger therapeutic agents and molecular structures such as amino acids, peptides, RNA, DNA and nucleotides. In addition, users can now copy and paste any sequence into the program to manipulate part or the entire section of a sequence in the search for modifications to gain a deeper understanding of their results and correlate biological activity with chemical structures.

To assess the shape and properties of small molecules and biochemical compounds, the ChemBio3D program enables synthetic chemists and biologists to generate 3D models. The ChemBio3D program can evaluate data input and provide valuable information such as the degree of fit of compounds into a receptor. In addition, the program acts as a hub for other 3D modeling programs, providing easy and consistent access to other computational and molecular modeling programs.

The addition of a sharable cloud location into the ChemBioOffice makes it easier for scientists to collaborate by securely sharing and importing ChemBioDraw and ChemBio3D structures, reactions and drawings with other scientists around the world.

A free two-week version of ChemBioOffice Ultra 13.0 and ChemBioDraw is available for download.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,300+ scientific posters on ePosters
  • More than 4,800+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

PerkinElmer Signals™ Perspectives Launches in Collaboration with Attivio
New data discovery solution leverages Attivio's platform to provide insight into complex scientific challenges.
Tuesday, February 02, 2016
PerkinElmer Revenues Grow 4%
PerkinElmer, Inc. reported financial results for the fourth quarter ended December 29, 2013.
Monday, February 03, 2014
CAS and PerkinElmer Combine the Power of SciFinder and ChemBioDraw
New functionality will enable ChemBioDraw users to search in SciFinder, providing access to comprehensive content available in the CAS databases.
Tuesday, December 17, 2013
PerkinElmer Announces Strategic Alliance with Integromics
PerkinElmer becomes the sole worldwide distributor of Integromics’ software for the TIBCO Spotfire.
Tuesday, June 25, 2013
PerkinElmer to Host Revolutionaries for Global Health Summit
Company to assemble thought leaders to share pioneering personalized health research and innovations.
Wednesday, May 01, 2013
PerkinElmer and MGH Pathology Collaborate
Collaboration to develop a complete sequencing informatics system for cancer research.
Wednesday, September 12, 2012
PerkinElmer Announces Acquisition of Geospiza
The acquisition of Geospiza supports PerkinElmer’s growing offerings in Next Generation DNA Sequencing and Analysis Services, enabling researchers to explore the genomic origins of disease more effectively.
Monday, May 16, 2011
PerkinElmer Signs Agreement to Acquire CambridgeSoft Corporation and Completes Purchase of ArtusLabs, Inc.
These acquisitions will enhance the Company’s focus on knowledge management in laboratory settings by expanding its informatics and software offerings.
Thursday, March 24, 2011
Scientific News
Connectome Map More Than Doubles Human Cortex’s Known Regions
Researchers at NIH have developed software that automatically detects the “fingerprint” of each of these areas in an individual’s brain scans.
Virus Inspired Cell Cargo Ships
Virus-inspired container design may lead to cell cargo ships following construction of ten large, two-component, icosahedral protein complexes.
Three-Drug Combinations Counter Antibiotic Resistance
Research shows that combinations of three different antibiotics can treat resistant bacteria, even if they are ineffective independently.
Supercomputing and Drug Discovery
New biotech company uses supercomputer simulations to speed up drug discovery and biotech molecule development.
Identifying Cancer Drug Targets Using 3D-Modelling
Researchers are now able to model genetic mutations manipulation of proteins that can potentially drive cancer.
Human Evolution Driven by Viruses
Study finds surprising percentage of protein adaptions in humans have been driven by viruses.
Earliest Sign of Alzheimer's Development Discovered
Researchers have identified the first physiological signs of late-onset Alzheimer's disease, underlining the importance of computational power in neurology.
Computational Method Offers Significant Boost in Finding New Cancer Targets
MIT and ARIAD Pharmaceuticals team have identified evidence of significant cancer mutations.
Drug Response Predicted by Cancer Cell Lines
Large-scale study could increase success rate of developing personalised cancer treatments.
Google and EI Partner for Next Generation of Coders
The Earlham Institute's open-source project for visualisation of biological data BioJS acts as mentor organisation for Google Summer of Code 2016.
Scroll Up
Scroll Down
SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,300+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,800+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!